Eli Lilly (LLY) PT Raised to $900 at BMO Capital
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $1,180.16 -2.25%
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
BMO Capital analyst Evan David Seigerman raised the price target on Eli Lilly (NYSE: LLY) to $900.00 (from $865.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Lilly files six lawsuits over illegal sales of unapproved retatrutide
- KP Tissue Inc. (KPT:CN) (KPTSF) PT Raised to Cdn$13.50 at Desjardins
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
